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Introduction
Actin is the most abundant protein in most, if not all, cell 
types, and the regulation of actin filament architecture is criti­
cal for proper cellular function. Striated muscle cells display 
one of the most extreme examples of actin filament organiza­
tion found in all of nature. The basic contractile units of stri­
ated muscle cells (sarcomeres) are composed of overlapping 
arrays of myosin (thick) and actin (thin) filaments that form a 
nearly crystalline structure. The thick and thin filaments inter­
act  with  and  slide  past  one  another  to  produce  contraction.   
Efficient contraction requires proper regulation of thin filament 
lengths. How the cell is able to specify and maintain these pre­
cise lengths is unknown. For more than two decades, the giant 
protein nebulin (600–900 kD) has been proposed by numerous 
investigators to function as a molecular ruler that defines the 
lengths of the thin filaments. Nebulin possesses several prop­
erties consistent with a function as a thin filament molecular 
ruler (Horowits, 2006; for reviews see Trinick, 1994; McElhinny 
et al., 2003). First, it extends along the entire length of the 
thin filament with its C terminus anchored within the Z­disc   
(a complex, protein­rich structure that connects two adjacent 
sarcomeres) and its N terminus extending out toward the center 
of the sarcomere (Wright et al., 1993). Second, the length of 
nebulin, which can vary as the result of alternative splicing, 
correlates with thin filament lengths in different muscle types 
(Kruger et al., 1991; Labeit et al., 1991). Finally, the unique 
protein structure of nebulin allows it to bind all the major com­
ponents of the thin filament. For example, human nebulin is 
composed of 185 tandem copies of an 35­aa repeat, each of 
which is thought to bind a single actin monomer (Jin and Wang, 
1991; Labeit et al., 1991; Pfuhl et al., 1994; Labeit and Kolmerer, 
1995). The majority of the repeats (modules 9–162) are also 
arranged into 22 consecutive seven­module super­repeats that 
match the periodicity of and are thought to interact with the 
thin filament components tropomyosin and troponin (Labeit and 
Kolmerer, 1995; Wang et al., 1996). Furthermore, the N terminus 
of nebulin binds the pointed end actin filament capping protein 
tropomodulin1 (Tmod1), which is located near the center of the 
sarcomere, whereas the C terminus interacts with the barbed 
end capping protein CapZ, which is located within the Z­disc 
(McElhinny et al., 2001; Pappas et al., 2008). Capping proteins 
effectively inhibit actin polymerization and depolymerization at 
the filament ends and are essential for proper thin filament 
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Results
Generation of a small synthetic nebulin 
molecule (mini-nebulin)
The definitive approach to determine if a molecule functions as a 
molecular ruler is to alter the size of the molecule and verify a 
corresponding change in the length of the structure it regulates. 
This has not been practical for nebulin because its large size and 
repetitive structure have precluded cloning of its full­length 
cDNA. To circumvent these problems, we designed a shorter ver­
sion of human nebulin, mini­nebulin, and had its coding sequence 
synthesized de novo (Fig. 1 A). Mini­nebulin is 250 kD in size 
and includes the unique N­ and C­terminal regions of nebulin 
plus 4 of nebulin’s 22 super­repeats (SR 1–3 and 22), resulting in 
a shorter molecule that retains all identified unique binding sites 
(e.g., Tmod, CapZ, desmin, myopalladin, etc.; Bang et al., 2001, 
2002; McElhinny et al., 2001; Pappas et al., 2008). Additionally, 
mini­nebulin contains a HA tag at its C terminus and a fluorescent 
tag (GFP or mCherry) at its N terminus. Mini­nebulin was intro­
duced into cultured chick skeletal myocytes, and the cells were 
analyzed by immunofluorescence microscopy. Localization of 
the GFP tag on mini­nebulin marked two distinct bands on either 
side of the Z­disc, indicating that the N terminus of mini­nebulin 
extends  away  from  the  Z­disc,  whereas  an  anti­HA  antibody 
stained within the Z­disc, indicating that the C terminus is located 
within the Z­disc (Fig. 1 B, arrowheads and arrows, respectively). 
The calculated mean distance between the N termini of mini­
nebulin molecules extending in opposite directions from the 
Z­disc was 0.45 ± 0.1 µm (n = 89), whereas the distance between 
the N termini of endogenous nebulin was 2 µm. Thus, full­
length mini­nebulin is successfully transcribed and translated and 
uniformly assembles in the same orientation as endogenous neb­
ulin but extends a shorter distance from the Z­disc. Because the 
sequence of mini­nebulin is based on that of human nebulin, 
siRNA targeted against chick nebulin transcripts should not affect 
its expression. To confirm this, we cotransfected mini­nebulin– 
and chick nebulin–specific siRNA into chick myocytes and ana­
lyzed the cell lysates by Western blotting. As expected, siRNA 
treatment reduced endogenous nebulin levels (700 kD) by 
>90%, whereas mini­nebulin levels (250 kD) remained un­
changed (Fig. 1 C).
Because of the very different sizes of mini­nebulin, which 
extends a short distance from the Z­disc, and endogenous 
nebulin, which extends nearly to the center of the sarcomere, 
both proteins could be detected simultaneously with an anti– 
N­terminal nebulin antibody in control cells (Fig. 2 A, e). (Note 
that the fluorescent secondary antibody used for the nebulin 
staining  [Texas  red]  was  visualized  in  the  same  channel  in 
which the mini­nebulin tag [mCherry] was detected. Thus, the 
mini­nebulin labeling is a combination of mCherry and Texas 
red signals.) Staining with the anti–N­terminal nebulin antibody 
also revealed that mini­nebulin was able to displace endogenous 
nebulin (Fig. 2 A, i, arrow). This displacement resulted in actin 
filaments that were more accessible to phalloidin staining and 
shorter (indicated by the presence of a distinct gap in phalloidin 
staining at the M­line that was not observed in the control myo­
cytes; Fig. 2 A, j, arrow). The length of the actin filaments from 
assembly and length regulation (e.g., Caldwell et al., 1989; Weber 
et al., 1994; Gregorio et al., 1995; Schafer et al., 1995; Sussman 
et al., 1998; Littlefield et al., 2001; Mudry et al., 2003). Thus, 
nebulin could specify the length of the thin filament by binding 
a specific number of actin and tropomyosin/troponin molecules 
and then recruit capping proteins, which would restrict assem­
bly to that defined length.
Recently, analysis of nebulin in vivo has revealed its critical 
role in maintaining proper skeletal muscle function. Nebulin­ 
deficient mice die within 2 wk of birth because of muscle weakness 
(Bang et al., 2006; Witt et al., 2006). Similarly, mutations in human 
nebulin can cause the muscle disorder nemaline myopathy, which 
is also characterized by muscle weakness (Pelin et al., 1999; 
Sanoudou and Beggs, 2001; Lehtokari et al., 2006). Analysis of 
skeletal muscle from nebulin knockout mice and tissue from pa­
tients with one specific mutation in nebulin that results in nema­
line  myopathy  revealed  that  both  have  shorter  thin  filaments 
(Bang et al., 2006; Witt et al., 2006; Ottenheijm et al., 2009). 
Identical results were also obtained after the knockdown of nebu­
lin in primary cultures of chick skeletal myocytes (Pappas et al., 
2008). These findings confirm that nebulin is essential for proper 
thin filament length regulation in skeletal muscle but do not pro­
vide a mechanism by which it functions.
Because of its giant size, susceptibility to proteolysis, and 
inability to purify it in its native state, progress in determining 
nebulin’s function has been slow. However, recent data have im­
plicated nebulin in a diverse range of cellular functions besides 
its proposed role as a thin filament molecular ruler. There is evi­
dence that nebulin regulates contraction, both by optimizing the 
interaction of actin and myosin and by controlling calcium han­
dling of the sarcoplasmic reticulum (Root and Wang, 1994, 2001; 
Ottenheijm et al., 2008; Bang et al., 2009; Chandra et al., 2009). 
Also, the C terminus of nebulin interacts with and appears to be 
regulated by the abundant intermediate filament protein desmin, 
suggesting that nebulin may be involved in maintaining the lat­
eral alignment of myofibrils, a property essential for coordinated 
and efficient contractile activity (Bang et al., 2002; Conover et al., 
2009; Tonino et al., 2010).
In this study, we set out to determine how nebulin regulates 
thin filament lengths by directly testing the molecular ruler hypoth­
esis. Here, we show that replacement of full­length endogenous 
nebulin with a small synthetic nebulin (mini­nebulin) in chick 
skeletal myocytes did not result in the assembly of shorter thin fil­
aments. Strikingly, however, after latrunculin A (Lat A)–induced 
actin depolymerization, the thin filaments that remained were 
never observed to depolymerize below the length of mini­nebulin, 
but either matched the length or were longer than mini­nebulin 
(e.g., full­length thin filaments). This indicates that mini­nebulin 
effectively stabilizes actin filaments of lengths equal to or greater 
than itself. Furthermore, endogenous nebulin also protected actin 
filaments from depolymerization and reduced the exchange of 
thin filament components. Mini­nebulin was able to reduce actin   
exchange at both ends of the filament, again indicating that it 
can effectively stabilize actin filaments that are longer than its 
own length. Mechanistically, these results indicate that nebulin 
regulates actin filament lengths by stabilizing the filaments and 
thereby preventing their depolymerization.861 Nebulin stabilizes actin filaments • Pappas et al.
In these myocytes, an N­terminal nebulin antibody stained bright 
bands flanking the Z­disc (corresponding to mini­nebulin) but 
did not stain near the center of the sarcomere (corresponding to 
endogenous nebulin; Fig. 2 B, e and i, arrows mark Z­discs). 
Strikingly,  when  cells  expressing  mini­nebulin  were  stained 
with fluorescently labeled phalloidin, actin filaments extending 
beyond the N­terminal end of mini­nebulin were clearly visible 
(Fig. 2 B, j and l, arrowheads). Extension of the thin filaments 
beyond the end of mini­nebulin was confirmed with an anti–
cardiac  actin  antibody  (unpublished  data). The  mean  length 
of the actin filaments from pointed end to pointed end was   
1.68 ± 0.08 µm (n = 53), which was not significantly differ­
ent than in the knockdown alone. To determine if a population 
of actin filaments matching the length of mini­nebulin was 
obscured by longer actin filaments, myocytes expressing mini­
nebulin were also stained for Tmod1, which marks the pointed 
ends of the actin filaments. Tmod1 staining was present in the 
pointed end to pointed end in these cells averaged 1.84 ± 0.13 µm   
(n = 57), which was 15% shorter than the length obtained 
from control cells lacking mini­nebulin (2.16 ± 0.09 µm; n = 48; 
P < 0.001; Fig. 2 A, b). See Materials and methods for details 
on measurements. These results remarkably mimic alternations 
in actin architecture observed after the siRNA­mediated knock­
down of nebulin (Fig. 2 B, b; Pappas et al., 2008). However, the 
knockdown of nebulin resulted in an 24% reduction in actin 
filament lengths (1.65 ± 0.06 µm; n = 48; P < 0.001). These data 
suggest that mini­nebulin assembles on the actin filament in a 
manner similar to endogenous nebulin.
Mini-nebulin does not restrict thin  
filament lengths
To directly test the proposed ruler function of nebulin, mCherry–
mini­nebulin  was  introduced  into  chick  skeletal  myocytes   
depleted of endogenous nebulin via nebulin­specific siRNA.   
Figure 1.  A small synthetic version of nebulin (mini-nebulin) assembles in the same orientation as endogenous nebulin in chick skeletal myocytes.  
(A) Schematic illustrating the structure of full-length human nebulin protein, which has 185 actin-binding modules of 35 residues (small boxes) that are 
flanked by unique N- (MADDE) and C-terminal (serine rich and SH3) domains. The central repeats are further organized into seven-module super-repeats 
(SR 1–22), which bind troponins and tropomyosins. Binding sites of the capping proteins Tmod and CapZ are also noted. To construct a smaller version 
of nebulin (mini-nebulin), super-repeats 4–21 were removed, resulting in a molecule that is approximately one third of the size of endogenous nebulin. 
Mini-nebulin was tagged with GFP (or mCherry) at its N terminus and HA at its C terminus. (B) Chick skeletal myocytes transfected with GFP–mini-nebulin 
were costained with antibodies to GFP and HA. GFP, and thus the N terminus of mini-nebulin, was located on either side of the Z-disc (arrowheads), 
whereas HA displayed a single band within the Z-disc (arrows). This is the identical orientation that endogenous nebulin adopts. Boxes indicate the area 
that is enlarged in the insets. (C) Western blot analysis with an anti–C-terminal nebulin antibody revealed that chick skeletal myocytes produced full-length 
mini-nebulin protein whose expression is not affected by chicken-specific nebulin siRNA, unlike that of endogenous nebulin. Equivalent protein loading 
was verified by Ponceau S staining. Molecular mass is indicated in kilodaltons. C, control (scrambled siRNA–treated cells); KD, knockdown (nebulin-
specific siRNA–treated cells). Bar, 10 µm.JCB • VOLUME 189 • NUMBER 5 • 2010   862
Figure 2.  Mini-nebulin can displace endogenous nebulin and does not restrict actin filament lengths or Tmod1 localization. (A) Chick skeletal myocytes 
cotransfected with control siRNA alone or control siRNA plus mCherry–mini-nebulin were triple stained with fluorescently conjugated phalloidin (which 
labels F-actin; b, f, and j) and antibodies to N-terminal nebulin (a, e, and i) and Tmod1 (c, g, and k). The antinebulin antibody recognized both endogenous 
nebulin (arrows) and mini-nebulin (arrowheads). The top row (a–d) is a cell with no detectable mini-nebulin. The middle row (e–h) is a cell with both assem-
bled mini-nebulin and endogenous nebulin. The bottom row (i–l) depicts a cell with mini-nebulin but no detectable endogenous nebulin. An asterisk marks 
protein aggregates that were often present in cells expressing the highest levels of mini-nebulin. Note that the displacement of endogenous nebulin resulted 
in shorter actin filaments as well as phalloidin staining along the entire length of the actin filaments, similar to what is observed in nebulin siRNA–treated 
cells. (B) Chick skeletal myocytes cotransfected with nebulin siRNA alone or nebulin siRNA plus mCherry–mini-nebulin were triple stained with fluorescently 
conjugated phalloidin (b, f, and j) and antibodies to N-terminal nebulin (a, e, and i) and Tmod1 (c and g) or -actinin (k). Both the pointed ends of the 
actin filaments (which extend well past; white arrowheads) and Tmod1 (asterisks) failed to colocalize with the N terminus of mini-nebulin. Arrows denote 
Z-discs, and yellow arrowheads indicate mini-nebulin. Boxes indicate the area that is enlarged in the insets. Bars, 10 µm.863 Nebulin stabilizes actin filaments • Pappas et al.
pointed ends of the actin filaments), whereas in cells lacking 
mini­nebulin, actin filaments were completely depolymerized 
or only observed within the Z­disc (Fig. 3 B, a–d). The locations 
of the pointed ends of the thin filaments (as a second marker for 
the length of the filaments) were then determined by staining 
for Tmod1 in cells extracted with a Triton X­100–containing 
buffer, which removes the cytosolic/soluble fraction of Tmod1, 
resulting in a clearer stain. In many cells, the localization of 
Tmod1 corresponded with the end of mini­nebulin, with no de­
tectable Tmod1 near the M­line (Fig. 3 C, example 1; Zs mark 
Z­discs and arrowheads mark N­terminal mini­nebulin–matching 
Tmod1). In other cells, the distribution of Tmod1 appeared at 
both the end of mini­nebulin and near the M­line (Fig. 3 C, 
example 2; asterisks mark M­line Tmod1), indicating that full­
length actin filaments as well as actin filaments at the length of 
mini­nebulin were present. Finally, a third population of cells 
had more intense Tmod1 staining near the M­line than at the 
end of mini­nebulin (Fig. 3 C, example 3). The percentage of 
the three distributions (i.e., examples 1–3) varied significantly 
(from 20 to 70%) from experiment to experiment, probably 
because of variations in cell density, maturation, efficiency of 
double transfections, and/or efficiency of depolymerization via 
Lat A. Notably, Tmod1 staining was not observed at lengths 
below that of mini­nebulin in any cell. However, in control cells 
treated with Lat A, Tmod1 staining was either punctate, with 
no recognizable assembly, or in distinct bands in close proxim­
ity to the Z­disc (likely marking the remnants of the depoly­
merized filaments; Fig. 3 C, top). To more clearly illustrate the 
location of actin and Tmod1 in relation to mini­nebulin after 
actin depolymerization, pixel intensity profiles of the staining 
along the longitudinal axis of the myofibrils were generated 
(Fig. 3 D). These data indicated that Lat A–induced actin de­
polymerization of full­length actin filaments was inhibited in 
the presence of mini­nebulin or progressed from the pointed   
ends of the filaments and stopped when reaching the N ter­
mini of mini­nebulin. These results indicate that mini­nebulin 
is capable of stabilizing thin filaments that are equal to or 
significantly longer than its own length. Therefore, nebulin 
functions to regulate thin filament architecture by preventing 
actin depolymerization.
Nebulin reduces the dynamics of thin 
filament components
If nebulin indeed stabilizes thin filaments, a reduction in nebulin 
levels would be predicted to increase the turnover of thin fila­
ment components. To test this, we used FRAP to determine the 
dynamics of thin filament proteins in chick skeletal myocytes. 
Myocytes were cotransfected with nebulin siRNA and GFP­ 
actin. The incorporation of GFP­actin differed in the knock­
down compared with the control. In control cells, GFP­actin as­
sembled in a narrow band at the barbed ends (Z­disc; Fig. S1 b,   
arrow) and a wider band at the location of the pointed ends, in 
the center of the sarcomere (Fig. S1 b, arrowheads), with little 
incorporation along the length of the filaments. Conversely, in 
nebulin knockdown cells, GFP­actin was incorporated evenly 
throughout the filaments (Fig. S1 f). This observation indicates 
that, in the absence of nebulin, the central region of the actin 
center of the sarcomere, at the location of the ends of actin fila­
ments which were significantly longer than mini­nebulin, but no 
Tmod1 staining was detected in the vicinity of the N terminus 
of mini­nebulin (Fig. 2 B, g and h, asterisks); this suggests an 
absence of actin filaments that match the length of mini­nebulin. 
These data also suggest that despite the presence of a Tmod1­
binding site, mini­nebulin is unable to direct the assembly of 
Tmod1. This is consistent with a recent report that Tmod1 and 
the N terminus of nebulin do not colocalize in various rabbit 
skeletal muscles (Castillo et al., 2009). Together, these data re­
veal that under these experimental conditions, mini­nebulin is 
unable to restrict actin lengths.
Nebulin stabilizes actin filaments
In a previous study, we observed that phalloidin stained along 
the entire length of the thin filaments in myocytes with reduced 
nebulin levels (Pappas et al., 2008). However, with nebulin levels 
unaltered, phalloidin staining was restricted to the ends of the fila­
ments (a phenomenon which had previously been reported; Ao 
and Lehrer, 1995; Zhukarev et al., 1997). These observations in­
dicated that nebulin and phalloidin compete for the same binding 
site on the actin filament. Accordingly, mini­nebulin is also able 
to inhibit phalloidin binding to actin filaments. A clear doublet of 
decreased phalloidin staining around the Z­disc was evident in 
cells expressing mini­nebulin (Fig. 2 B, f and j). Because phal­
loidin is known to bind to and stabilize actin filaments in vitro by 
reducing the dissociation rate of actin monomers from the poly­
mer (Coluccio and Tilney, 1984), we hypothesized that nebulin 
may function in a similar manner in skeletal muscle cells.
To test the hypothesis that nebulin stabilizes actin filaments, 
we treated chick skeletal myocytes that had reduced levels of 
nebulin with the actin­depolymerizing agent Lat A. Cells depleted 
of nebulin displayed nearly complete depolymerization of actin 
filaments, as determined by staining with fluorescently labeled 
phalloidin. In many cells, only remnants of actin filaments within 
the Z­disc remained, marked by colocalization with ­actinin, an 
integral Z­disc protein (Fig. 3 A, e–h, arrows). This is not surprising 
because of the high number of actin­binding proteins within the 
Z­disc (for review see Clark et al., 2002). Conversely, actin fila­
ments in myocytes treated with control siRNA were nearly un­
affected by Lat A treatment (Fig. 3 A, a–d), a result which has 
been previously documented (Wang et al., 2005a). Because Lat A 
functions to depolymerize filaments by binding to monomeric 
actin (preventing its association with the polymer; Coué et al., 
1987), the susceptibility of nebulin­deficient actin filaments to 
Lat A treatment suggests that nebulin significantly stabilizes   
actin–actin monomer associations within the filament.
Mini-nebulin stabilizes short and long  
actin filaments
To test whether mini­nebulin, like full­length endogenous nebu­
lin, is capable of stabilizing actin filaments, we added Lat A to 
nebulin­depleted cells expressing mini­nebulin. Remarkably, in 
mini­nebulin–positive cells, actin filaments extended out from 
the Z­disc to a length that either matched or extended beyond 
the N terminus of mini­nebulin (Fig. 3 B, examples 1 and 2, 
respectively; arrows denote Z­discs and arrowheads mark the JCB • VOLUME 189 • NUMBER 5 • 2010   864
left; and Fig. S2). The mobile fractions from multiple experi­
ments were determined from nonlinear regression curves fitted 
using a two­exponential association equation (Fig. 4 A, right). 
A significant increase in the mean slow mobile fraction was ob­
served in cells with reduced levels of nebulin, whereas the mean 
fast mobile fraction remained unchanged. Thus, reducing the 
levels of nebulin increases the number of actin molecules that 
are able to exchange, which is consistent with the removal of a 
stabilizing mechanism.
filament is more subject to actin turnover. This differential pattern 
of incorporation is nearly identical to that observed after phal­
loidin staining in both control and nebulin knockdown cells. 
Thus, the portion of the actin filament that is accessible to phal­
loidin (i.e., regions not associated with nebulin) also appears 
to be accessible to GFP­actin incorporation. Cells were photo­
bleached in a defined area around the barbed (Z­disc) or pointed 
ends (center of the sarcomere) of the actin filaments and the 
recovery of fluorescence over time was monitored (Fig. 4 A, 
Figure 3.  Lat A treatment of chick skeletal myocytes with reduced nebulin levels results in actin filament depolymerization, whereas the introduction of 
mini-nebulin in these myocytes protects the filaments from depolymerization. (A) Myocytes treated with Lat A for 9 h, 3 d after transfection of siRNA, 
were triple stained with fluorescently conjugated phalloidin (b and f) and antibodies to N-terminal nebulin (a and e) and -actinin (c and g). The nebulin 
siRNA–treated cells (e–h) contained only remnants of F-actin at the Z-disc (arrows), whereas control siRNA–treated (a–d) cells were resistant to depolymer-
ization, as indicated by the presence of full-length actin filaments (arrowheads mark the pointed ends). (B and C) Myocytes were cotransfected with nebulin 
siRNA and mCherry or mCherry–mini-nebulin and then treated with Lat A for 20–24 h, 5 d after transfection. (B) Cells were triple stained with fluorescently 
conjugated phalloidin (b, f, and j) and antibodies to N-terminal nebulin (a, e, and i) and -actinin (c, g, and k). Cells expressing mini-nebulin had actin 
filaments that matched the length of mini-nebulin (example 1: e–h, arrowheads) or extended beyond the N-terminal end of mini-nebulin (example 2: i–l, 
arrowheads). Control cells again displayed actin filaments that were completely depolymerized or only observed within the Z-disc (a–d). Arrows denote the 
Z-discs. (C) Myocytes were also costained with an antibody to Tmod1 as a marker of actin filament pointed ends (b, e, h, and k). Example 1 (d–f) shows 
Tmod1 localization only in close proximity to the N termini of mini-nebulin (arrowheads). Example 2 (g–i) illustrates Tmod1 localization in close proxim-
ity to the N termini of mini-nebulin (arrowheads) and near the M-line (asterisks). Example 3 (j–l) shows more intense Tmod1 localization near the M-line 
(asterisks) than near the N termini of mini-nebulin (arrowheads). Zs denote the Z-discs. Note that cells were extracted in a Triton X-100–containing buffer 
before fixation to obtain a clearer Tmod1 stain; thus, most of the diffuse mCherry was removed with this treatment (top, nebulin). (A–C) Boxes indicate the 
area that is enlarged in the insets. (D) Pixel intensity plots of mini-nebulin and actin (top) or mini-nebulin and Tmod1 (bottom) from the examples illustrated 
in B and C (indicated by matching colored asterisks). The percentage of maximum intensity versus position of each pixel along the length of a myofibril is 
plotted. Each plot is centered on a single Z-disc and encompasses two half sarcomeres. Bars, 10 µm.865 Nebulin stabilizes actin filaments • Pappas et al.
mobile fraction of barbed end actin associated with mini­nebulin 
was nearly identical to that observed in cells containing endoge­
nous nebulin (Fig. 4 A, control siRNA). Therefore mini­nebulin 
decreases the number of actin molecules that exchange with the 
barbed and pointed ends of the thin filament, which is consistent 
with the addition of an actin stabilizer. Furthermore, these results 
support the Lat A experimental data, indicating that mini­nebulin 
can stabilize actin filaments without matching their lengths.
Discussion
In this study, we used a combination of tools to manipulate the 
architecture of actin filaments in skeletal muscle to determine 
how the giant molecule nebulin contributes to actin filament 
length regulation. Skeletal myocytes in culture were ideal for 
this study because we were able to significantly reduce endoge­
nous levels of nebulin via siRNA, introduce a unique, small re­
combinant nebulin molecule (mini­nebulin), and chemically 
depolymerize the actin filaments. This combination of ap­
proaches could not be accomplished in intact animal models. 
Importantly, the sarcomeric alterations observed after the knock­
down of nebulin in chick skeletal myocytes in culture match 
those observed after the knockout of nebulin in mice. Namely, 
both have shorter thin filaments, the presence of nemaline bod­
ies, and wide, misaligned Z­discs (Bang et al., 2006; Witt et al., 
2006; Pappas et al., 2008; unpublished data). Our data show that 
nebulin is not sufficient to function as a strict molecular ruler 
To ascertain whether nebulin affects the dynamics of other 
thin filament components, the recoveries of GFP­tropomyosin 
and GFP­Tmod1 after photobleaching were also analyzed.   
Similar to the results obtained with GFP­actin, the mean slow 
mobile fractions of recovery of both tropomyosin and Tmod1 
significantly increased in cells with reduced nebulin (Fig. 4,   
B and C, respectively). The increase in the number of exchangeable 
tropomyosin and Tmod1 molecules could be directly caused 
by the loss of the nebulin or indirectly caused by the increase in 
actin dynamics.
To further establish that mini­nebulin is capable of stabiliz­
ing actin filaments, chick skeletal myocytes were cotransfected 
with  mCherry–mini­nebulin,  GFP­actin,  and  nebulin  siRNA. 
GFP­actin around the Z­disc or M­line was bleached, and recov­
ery of fluorescence was monitored. Remarkably, introduction of 
mini­nebulin rescued the increased actin dynamics observed at 
both the barbed (Fig. 5 A) and pointed ends (Fig. 5 B) of the   
actin filaments seen when nebulin was depleted. In fact, the mean 
Figure 4.  The knockdown of nebulin in chick skeletal myocytes results in 
more dynamic thin filament components revealed by FRAP. (A–C) Recovery 
after photobleaching of GFP–skeletal actin (A), GFP-tropomyosin (B), and 
GFP-Tmod1 (C) in control versus nebulin siRNA–treated chick skeletal myo-
cytes. (left) Mean relative recovery from single representative experiments 
(n = 4–11 per treatment). (right) Mean slow and fast mobile fractions from 
two to three experiments (n = 8–17 cells per treatment). GFP–skeletal actin 
was bleached either at the Z-disc or M-line. Values are means ± SEMs. 
Asterisks indicate significant differences between treatments (*, P < 0.05; 
**, P < 0.01; Student’s t test).
Figure 5.  Mini-nebulin recovers actin dynamics at both ends of the actin 
filament in cells with reduced levels of nebulin. (A and B) Evaluation of 
the recovery after photobleaching of GFP–skeletal actin at the Z-disc (A) 
or M-line (B) in nebulin siRNA– versus nebulin siRNA plus mCherry–mini-
nebulin–transfected chick skeletal myocytes. (left) Mean relative recovery 
curve from a representative experiment (Z: n = 4–5; M: n = 6–8 cells per 
treatment). (right) Mean slow and fast mobile fractions from two experiments 
(Z: n = 8–10; M: n = 12 cells per treatment). Values are means ± SEMs. 
Asterisks indicate significant differences between treatments (*, P < 0.05; 
**, P < 0.01; Student’s t test).JCB • VOLUME 189 • NUMBER 5 • 2010   866
know, our study provides the only direct evidence to date that 
nebulin stabilizes actin directly in cells and that this stability 
contributes to proper length maintenance.
We cannot rule out the possibility that because of its small 
size (one third of the size of endogenous nebulin), the ruler activ­
ity of mini­nebulin was rendered ineffective by the large amount 
of globular actin (G­actin) present when the thin filaments are 
that short. Nevertheless, the fact that mini­nebulin can influence 
the stability of portions of the actin filament with which it is not 
in immediate contact is also inconsistent with the classical model 
of a molecular ruler. Further evidence contradicting a strict ruler 
function of nebulin is its absence in most invertebrate skeletal 
muscles, which have regulated actin filament lengths. In fact, 
many invertebrates have extraordinarily long sarcomeres (e.g., 
10 µm in the tarsonemid mite; Aronson, 1961); consequently, if 
nebulin were present, it would have to be approximately five 
times the length of vertebrate nebulin to function as a ruler, 
which seems unlikely. Thus, although nebulin may not function 
as an indispensable molecular ruler, we would predict, based on 
our data, that it provides a higher­order stabilization mechanism 
in vertebrates that is not required in lower organisms.
How can a change in actin filament stability translate to a 
change in thin filament lengths? An increase in actin dissocia­
tion caused by the loss of a stabilizer (e.g., nebulin) would likely 
increase the critical concentration of G­actin required for poly­
merization. Furthermore, Tmod has a much higher affinity for the 
pointed ends of actin filaments that are associated with tropomyo­
sin (Weber et al., 1994). Therefore, more dynamic tropomyosin 
(caused by the loss of nebulin) would be predicted to result in 
more dynamic Tmod, with a lower affinity for the pointed end 
of the actin filament (which is consistent with our FRAP data). 
Less efficient Tmod capping (i.e., in the absence of tropomyo­
sin) has been proposed to result in an increase in the critical con­
centration of actin in vitro (Weber et al., 1999). Therefore, this 
combined increase in the concentration of G­actin required for 
polymerization could result in a cell state in which the steady­
state of exchange between G­actin and the filament is reached at 
a shorter mean filament length; this could explain the shorter thin 
filaments observed in nebulin knockout and knockdown models 
(Bang et al., 2006; Witt et al., 2006; Pappas et al., 2008).
How can nebulin confer stability to portions of the actin fila­
ment it does not associate with? One possible mechanism is that 
by stabilizing the Z­disc/I­band portion of the thin filament, nebu­
lin may alter the structure of any individual or synergistic group 
of thin filament–associated proteins that may confer stability to 
the whole filament (e.g., titin and tropomyosin). Tropomyosin is 
an especially good candidate because it binds along the entire 
thin filament and is stabilized by nebulin. Clearly, extensive struc­
tural studies of thin filaments with and without nebulin are war­
ranted in the future.
Our data demonstrate the ability of nebulin to inhibit 
the depolymerization of the actin filament but do not provide 
evidence that nebulin plays a role in regulating actin filament   
polymerization. Therefore, other factors such as Tmod may be 
involved in restricting the growth of actin filaments (Castillo   
et al., 2009; for review see Littlefield and Fowler, 2008). Alterna­
tively, when actin filaments reach their final lengths, the cell may 
(i.e., one in which the length of nebulin matches the length of the 
actin filaments) for specification of thin filament lengths because 
mini­nebulin was unable to restrict the growth of actin filaments 
or localize Tmod1. Instead, our data demonstrate that nebulin 
regulates thin filament lengths by decreasing actin depolymer­
ization and thereby stabilizing the filaments.
Treatment of mature skeletal myocytes with the actin 
monomer–sequestering drug Lat A had remarkably little effect on 
actin filament architecture, indicating that the dissociation rate of 
actin monomers from the polymer was very low. However, after 
the removal of nebulin, actin filaments depolymerized upon   
Lat A treatment, demonstrating that the dissociation rate of actin 
monomers from the polymer filament had considerably increased. 
Additionally, using FRAP, we showed that nebulin reduces the 
dynamic exchange of actin, tropomyosin, and Tmod1 in the thin 
filaments. Because nebulin contains an unparalleled number of 
tandem actin­binding domains (200), which have the potential 
to make numerous molecular contacts with the actin filament, it 
likely directly stabilizes the filament. However, because nebulin 
also binds to tropomyosin and tropomyosin itself has been shown 
to stabilize actin filaments (Broschat, 1990; Wang et al., 1996; 
Cooper, 2002), we predict that these two molecules act synergis­
tically to produce mature filaments that are highly resistant to de­
polymerization. Finally, nebulin could also protect the actin 
filament from depolymerization factors such as DNaseI and ADF 
(actin­depolymerizing factor)/cofilin or severing by gelsolin, which 
has been shown to be an attribute of tropomyosin (Hitchcock   
et al., 1976; Bernstein and Bamburg, 1982; Fattoum et al., 1983; 
Ono and Ono, 2002).
We also showed that the length of nebulin determined the 
extent to which the actin filament was stabilized. When we re­
placed endogenous nebulin with mini­nebulin, only the portion of 
the thin filament not associated with mini­nebulin was suscepti­
ble to depolymerization because actin filaments shorter than 
mini­nebulin were not observed (both by phalloidin and Tmod1 
staining). Surprisingly, mini­nebulin also transmitted stability to 
the entire actin filament, as indicated by its increased resistance to 
Lat A depolymerization, and decreased actin dynamics at both 
ends of the filament.
Our results support a model of thin filament length regula­
tion in which nebulin dictates the minimal length at which the 
thin filament is stabilized and permits the filament to elongate to 
its final physiological length (Bang et al., 2006; Gokhin et al., 
2009; for review see Littlefield and Fowler, 2008). Our data are 
also consistent with previous studies that demonstrated (a) via 
immunofluorescence microscopy that thin filaments extend past 
the N terminus of nebulin (Castillo et al., 2009), (b) that a two­
module nebulin fragment is able to prevent actin depolymeriza­
tion in vitro (Chen et al., 1993), and (c) that fluorescently labeled 
actin was more stable in myofibrils that had a mature staining 
pattern of nebulin (Nwe et al., 1999). Furthermore, studies of 
nebulin knockout mice have revealed that sarcomere structure 
and function progressively worsen with age and contractile ac­
tivity (Bang et al., 2006; Witt et al., 2006; Chandra et al., 2009; 
Gokhin et al., 2009; Tonino et al., 2010), which could be the   
result of some level of thin filament depolymerization caused by 
a lack of nebulin­induced actin filament stability. As far as we 867 Nebulin stabilizes actin filaments • Pappas et al.
human mutation in nebulin, which results in nemaline myop­
athy, to improper (shorter) actin filament length regulation   
(Ottenheijm et al., 2009). Regulation of actin filaments lengths by 
nebulin also appears to be linked to certain desmin­related myop­
athies. Desmin is an abundant intermediate filament protein that 
localizes to the periphery of the Z­disc, where it interacts with   
C­terminal nebulin, and may function to laterally align adjacent 
myofibrils (Granger and Lazarides, 1979; Milner et al., 1996; Li 
et al., 1997; Bang et al., 2002; Tonino et al., 2010). Desmin­related 
myopathies result in skeletal muscle weakness, which is also often 
accompanied by cardiomyopathy (Goldfarb et al., 2004). At 
the cellular level, the disease is characterized by the presence of 
cytoplasmic protein aggregates that contain desmin. One specific 
mutation of desmin, which causes desmin­related myopathy, is 
located within the nebulin­binding domain. Introduction of des­
min with this mutation into myocytes in culture leads to reduced 
nebulin assembly and unregulated actin filament lengths, which 
is consistent with defects observed in the human disease (Conover 
et al., 2009). Therefore, our study, which describes how nebulin 
regulates actin filament length, adds to a more complete under­
standing of these disease processes.
Nebulin regulation of actin filament length is likely not re­
stricted to skeletal muscle because nebulin is expressed in a vari­
ety of other tissues that exhibit defined actin lengths, including 
the heart, kidney, eye, otic canal, and liver (Kazmierski et al., 
2003; Bang et al., 2006). Finally, our results suggest that other 
proteins with multiple tandem actin­binding sites will have the 
potential to regulate actin filament architecture by a stabiliza­
tion mechanism.
Materials and methods
Cell culture and siRNA treatment
Primary cultures of chick skeletal myocytes were prepared as described 
previously (Nawrotzki et al., 1995) with minor modifications. In brief, 
breast muscle was dissected from three to five 11-d-old chicken embryos, 
pooled, minced with scissors, and suspended in a 0.05% trypsin-EDTA 
solution (Cellgro). Cells were dissociated by gentle pipetting. The activity 
of trypsin was then quenched by adding growth medium (12.5% horse 
serum [HyClone], 12.5% chicken embryo extract, and 5 mM l-glutamine 
[Cellgro] in MEM [Cellgro]). The cell suspension was then centrifuged, 
resuspended in new growth medium, filtered with a 70-µm cell strainer 
(BD), and plated on uncoated culture dishes for 30 min, two times to re-
move fibroblasts. 9.5 × 10
5 unattached cells were plated on Matrigel (BD)-
coated coverslips in a 35-mm dish. After 2 d, the growth medium was 
replaced with differentiation medium (12.5% horse serum, 2% chicken   
embryo extract, and 4.5 mM glutamine in MEM) that, if necessary, contained 
1 µg/ml cytosine -d-arabinofuranoside to prevent fibroblast proliferation. 
A nebulin-specific siRNA we previously designed and validated (Pappas   
et al., 2008) was purchased from Applied Biosystems (target cDNA   
sequence, 5-GTAGCTGACTCTCCAATTA-3). Random siRNA was also 
purchased  (target  cDNA  sequence,  5-CTCGACTAGAGTCTGTCTA-3).   
Skeletal myocytes were transfected 13 h after plating with 50 nM of 
siRNA using the lipid-based reagent Effectene (QIAGEN) according to the 
manufacturer’s instructions. For cotransfection experiments, GFP fusion ex-
pression constructs of 0.5–1 µg chicken Tmod1, chicken skeletal -actin, 
and rat -tropomyosin (gift from J.C. Perriard, Eidgenössische Technische 
Hochschule Zürich, Zürich, Switzerland; Helfman et al., 1999) were trans-
fected 4 h after siRNA treatment to avoid toxicity problems. 3–5 d after 
transfection, the cells were incubated in relaxing buffer (150 mM KCl, 
5 mM MgCl2, 10 mM MOPS, pH 7.4, 1 mM EGTA, and 4 mM ATP) 
for 15 min and fixed with 2% paraformaldehyde in relaxing buffer for   
15 min. When indicated, the cytosol of cells was extracted in cytoskeleton 
stabilization buffer (10 mM Pipes, pH 6.8, 100 mM KCl, 300 mM sucrose, 
2.5 mM MgCl2, and 0.5% Triton X-100 plus the protease inhibitors) before 
be in a state that does not favor actin polymerization, and full­
length actin filaments are maintained by the protection afforded 
by nebulin and tropomyosin. In support of this hypothesis, the 
concentration of G­actin is considerably lower in adult compared 
with embryonic chicken skeletal muscle (Shimizu and Obinata, 
1986). In any case, it is clear from our present and previous stud­
ies as well as work from many other laboratories (for reviews 
see Littlefield and Fowler, 1998, 2008) that regulation of thin 
filament architecture requires the coordinated activity of many 
molecules/mechanisms.
Interestingly, Wang et al. (2007) reported that the dynamics 
of tropomyosin decrease as premyofibrils develop into mature 
myofibrils in skeletal myocytes. This is consistent with our data 
because nebulin is not found in its mature conformation in pre­
myofibrils (Wang et al., 2007). In addition, tropomyosin is more 
dynamic in mature cardiac myocytes, which contain only minor 
amounts of nebulin, than in mature skeletal myocytes, in which 
nebulin is highly expressed (Wang et al., 2008).
The N terminus of nebulin associates with the pointed end 
of the actin filament near the center of the sarcomere, whereas 
the C terminus is located at the barbed end of the filament within 
the Z­disc (Wright et al., 1993). Previous studies have shown 
that only C­terminal fragments of nebulin associate with the 
thin filament when expressed in myocytes in culture, suggesting 
that the Z­disc portion of nebulin is necessary for its assembly 
(Ojima et al., 2000; Panaviene et al., 2007). Mini­nebulin, which 
we constructed with the complete unique N and C termini of 
nebulin (i.e., only the central region of nebulin was removed), 
assembled with its C­terminal end within Z­disc and N­terminal 
region extending out from the Z­disc. This observation indicates 
that the C terminus of nebulin directs its assembly and supports a 
model in which the C terminus of nebulin first associates with the 
Z­disc, and then the rest of the molecule assembles (zippers) 
along the thin filament (Chen et al., 1993). Because of the number 
of actin­binding repeats present within its structure, one molecule 
of mini­nebulin, if linear, would be predicted to extend 325 nm 
along the actin filament. Therefore, two molecules of mini­nebulin 
extending in opposite directions from the center of the Z­disc 
would measure 650 nm from end to end. However, the mea­
sured distance from end to end was 450 nm. This suggests that 
molecules of nebulin extensively overlap within the Z­disc, with 
the last super­repeat (22) located at the edge of the Z­disc. This 
result is consistent with a previous model of the molecular layout 
of nebulin within the Z­disc, which was based on the identifica­
tion of binding sites of integral Z­disc proteins within nebulin 
(Pappas et al., 2008).
Understanding how nebulin functions is of particular im­
portance because mutations in nebulin are the most common 
cause of the human muscle disorder nemaline myopathy (Pelin   
et al., 1999; Lehtokari et al., 2006). Nemaline myopathy is charac­
terized by muscle weakness usually in the upper body, and its se­
verity can vary from mild, with late onset and slow progression, 
to severe, with neonatal lethality caused by respiratory problems 
(Sanoudou and Beggs, 2001). A hallmark of the disease is the 
presence of rodlike nemaline bodies in the muscle fibers that are 
composed of aberrantly arranged Z­disc and thin filament (I­band) 
proteins. Notably, a recent study has directly linked a specific JCB • VOLUME 189 • NUMBER 5 • 2010   868
background regions were recorded. After background subtraction and   
correction for photobleaching caused by image acquisition, intensities were 
normalized so that prebleach intensity was set to 1 and postbleach intensity 
was set to 0. Mobile fractions were determined from nonlinear regression 
curves  that  were  best  fit  using  a  two-exponential  association  equation   
(R = M(fast) × (1  exp(k1 × t)) + M(slow) × (1  exp(k2 × t))) with Prism 4 
software (GraphPad Software, Inc.). R is the relative recovery at time t, and 
the total mobile fraction is the combination of M(fast) and M(slow). For the recov-
ery experiments, control cells were treated with nebulin-specific siRNA alone 
or siRNA plus mCherry. 4–11 cells per treatment were analyzed in each ex-
periment and two to three experiments  were  averaged.  All  values  are 
means ± SEM, and two-tailed, unpaired Student’s t tests were used to de-
termine the significance of differences (Excel). After the FRAP experiments, 
the cells were fixed and stained to confirm knockdown of nebulin.
Mini-nebulin design, construction, and analysis
Mini-nebulin  was  designed  using  the  coding  sequence  of  human  nebu-
lin  (available  from  GenBank/EMBL/DDBJ  under  accession  number   
NM_004543) and the structural organization characterized by Labeit and 
Kolmerer (1995). To reduce the size of nebulin, 18 super-repeats were re-
moved (SR 4–21), leaving the unique N and C termini and 4 super-repeats 
remaining (SR 1–3 and 22; Fig. 1 A). This resulted in a shorter molecule 
that retained all of its known unique binding sites. A four-residue glycine 
linker followed by a HA tag was added to the C terminus. After optimization 
of codon usage for chicken and removal of unwanted restriction enzyme 
recognition sites through synonymous nucleotide substitutions, the sequence 
was synthesized by GenScript Corp. Mini-nebulin was then inserted into 
the multicloning site of pEGFP-C2 (Takara Bio Inc.) using XhoI and SacI re-
striction sites, which fused GFP to the N terminus of mini-nebulin. The final 
mini-nebulin–GFP construct was 11.6 kb and resulted in a 2,543-residue 
protein. Mini-nebulin was also inserted into a modified pEGFP-C2 vector 
in which GFP was replaced with mCherry. An anti-GFP or anti–N-terminal 
nebulin antibody was used for analysis of mini-nebulin by immunofluores-
cence microscopy. Localization of the HA tag to the Z-disc was confirmed by 
costaining for -actinin.
Online supplemental material
Fig. S1 shows that in control cells, GFP-actin assembles at the ends of the 
thin filaments, but in nebulin-depleted cells, it incorporates uniformly along 
the length of the thin filaments. Fig. S2 depicts a series of timed images from 
representative FRAP experiments. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.201001043/DC1.
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